Literature DB >> 7113941

Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease.

R Whittemore, J C Hobbins, M A Engle.   

Abstract

In the state of Connecticut, 233 women with congenital heart defects were prospectively followed up through 482 pregnancies that resulted in 372 infants who were examined frequently during their first 3 years of life. Approximately half of the women had undergone cardiac surgery and they were compared with the women without operation. There was no maternal mortality, and no patient had infective endocarditis, brain abscess or a cerebrovascular accident. The proportion of pregnancies resulting in live births did not differ significantly in mothers with and without cardiac surgery; the average live birth rate was 77 percent in all. However, the number and size of live-born infants was much greater in mothers who had become acyanotic as a result of reparative surgery than in the still cyanotic women, whether or not they had had palliative surgery. In cyanotic women, placental size was abnormally large in relation to birth weight, which was abnormally low. When the mothers were classified according to cardiac function, there was a significant difference between the number of infants born alive to mothers in good to excellent status and the number born to mothers in fair to poor condition. The latter had a significant increase in interrupted pregnancies as well as in cardiovascular complications during pregnancy. The total group had a 16.1 percent incidence rate of infants with congenital heart disease. This rate was corrected to 14.2 percent by removal of seven mothers, two with Noonan's syndrome, one with hypertrophic cardiomyopathy and four with a family history of congenital heart defects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7113941     DOI: 10.1016/0002-9149(82)90334-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  38 in total

1.  Value of antenatal echocardiography in high risk patients to diagnose congenital cardiac defects in fetus.

Authors:  A Saxena; S Shrivastava; S S Kothari
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

Review 2.  Heart disease and pregnancy.

Authors:  S C Siu; J M Colman
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

Review 3.  Indications for fetal echocardiography.

Authors:  M Small; J A Copel
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

4.  Risk factors for cardiovascular malformations in Finland.

Authors:  J Tikkanen; O P Heinonen
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

5.  [Heart diseases in pregnancy].

Authors:  Vera Regitz-Zagrosek; Christa Gohlke-Bärwolf; Annette Geibel-Zehender; Markus Haass; Harald Kaemmerer; Irmtraut Kruck; Christoph Nienaber
Journal:  Clin Res Cardiol       Date:  2008-09       Impact factor: 5.460

6.  Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis.

Authors:  W Drenthen; P G Pieper; J W Roos-Hesselink; A C M Schmidt; B J M Mulder; A P J van Dijk; H W Vliegen; K M Sollie; A A Voors; T Ebels; D J van Veldhuisen
Journal:  Heart       Date:  2006-07-03       Impact factor: 5.994

7.  Long-term outlook in treated congenital heart disease.

Authors:  S Thorne; J Deanfield
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

Review 8.  Complex genetics and the etiology of human congenital heart disease.

Authors:  Bruce D Gelb; Wendy K Chung
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

9.  Diagnosis and natural history of Ebstein's anomaly.

Authors:  D J Radford; R F Graff; G H Neilson
Journal:  Br Heart J       Date:  1985-11

10.  The first open heart corrections of tetralogy of Fallot. A 26-31 year follow-up of 106 patients.

Authors:  C W Lillehei; R L Varco; M Cohen; H E Warden; V L Gott; R A DeWall; C Patton; J H Moller
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.